Licensing & Co-Development Deals
Generic｜ 505(b)(2)｜ clinical-stage new drug
Licensing & Co-Development Deals
Whether you are out-licensing or in-licensing, the key is to align each product with the right partners, the right market positioning, and the right strategy.
Apexray focuses on licensing and co-development for generics, 505(b)(2) products, and clinical-stage drug candidates. We support clients across the full licensing continuum – from asset and commercial value assessment, target indication and market selection, through partner mapping, deal-structure design, and term negotiation.
This service can help you:
Conduct commercial opportunity and competitive landscape assessments for your product and indication, evaluating market size, price bands, and existing treatment options to identify realistic entry points
Design licensing territory packages and deal economics (upfronts, milestones, royalties, territory splits, etc.), supported by high-level financial modelling and scenario analysis
Build a shortlist of potential licensing and co-development partners, identify the right decision-makers, and help arrange focused 1:1 business meetings
Provide hands-on support from BD deck development and data room preparation through to due diligence documentation, so your licensing discussions can move forward in a structured and consistent way
Contact Us
Reach out with any questions or requests about our services.